Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Fayers

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
BMC Palliative Care|October 25, 2013
A randomised, multicentre clinical trial of specialised palliative care plus standard treatment versus standard treatment alone for cancer patients with palliative care needs: the Danish palliative care trial (DanPaCT) protocolAnna T Johnsen, Anette Damkier, Tove B Vejlgaard, et al.
BMJ Supportive & Palliative Care|November 14, 2019
Inclusion of older patients with cancer in randomised controlled trials with patient-reported outcomes: a systematic reviewFrancesco Sparano, Neil K Aaronson, Mirjam A G Sprangers, et al.
Palliative Medicine|May 13, 2017
Randomised clinical trial of early specialist palliative care plus standard care versus standard care alone in patients with advanced cancer: The Danish Palliative Care TrialMogens Groenvold, Morten Aagaard Petersen, Anette Damkier, et al.
Trials|September 27, 2014
Detailed statistical analysis plan for the Danish Palliative Care Trial (DanPaCT)Anna Thit Johnsen, Morten Aagaard Petersen, Christian Gluud, et al.
Plos Medicine|May 15, 2014
Methods for specifying the target difference in a randomised controlled trial: the Difference ELicitation in TriAls (DELTA) systematic reviewJenni Hislop, Temitope E Adewuyi, Luke D Vale, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 12, 2019
Validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Summary Score in Patients With Hematologic MalignanciesFabio Efficace, Francesco Cottone, Kathrin Sommer, et al.
Health Technology Assessment (Winchester, England)|May 9, 2014
Assessing methods to specify the target difference for a randomised controlled trial: DELTA (Difference ELicitation in TriAls) reviewJonathan A Cook, Jennifer Hislop, Temitope E Adewuyi, et al.
Journal of Pain and Symptom Management|November 5, 2016
Development of the EORTC QLQ-CAX24, A Questionnaire for Cancer Patients With CachexiaSally J Wheelwright, Jane B Hopkinson, Anne-Sophie Darlington, et al.
The Lancet. Oncology|September 25, 2010
Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trialPeter Gimsing, Kristina Carlson, Ingemar Turesson, et al.
Targeted Oncology|November 9, 2020
Developing Symptom Lists for People with Cancer Treated with Targeted TherapiesSamantha C Sodergren, Sally J Wheelwright, Deborah Fitzsimmons, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
BMC Palliative Care|October 25, 2013
A randomised, multicentre clinical trial of specialised palliative care plus standard treatment versus standard treatment alone for cancer patients with palliative care needs: the Danish palliative care trial (DanPaCT) protocolAnna T Johnsen, Anette Damkier, Tove B Vejlgaard, et al.
BMJ Supportive & Palliative Care|November 14, 2019
Inclusion of older patients with cancer in randomised controlled trials with patient-reported outcomes: a systematic reviewFrancesco Sparano, Neil K Aaronson, Mirjam A G Sprangers, et al.
Palliative Medicine|May 13, 2017
Randomised clinical trial of early specialist palliative care plus standard care versus standard care alone in patients with advanced cancer: The Danish Palliative Care TrialMogens Groenvold, Morten Aagaard Petersen, Anette Damkier, et al.
Trials|September 27, 2014
Detailed statistical analysis plan for the Danish Palliative Care Trial (DanPaCT)Anna Thit Johnsen, Morten Aagaard Petersen, Christian Gluud, et al.
Plos Medicine|May 15, 2014
Methods for specifying the target difference in a randomised controlled trial: the Difference ELicitation in TriAls (DELTA) systematic reviewJenni Hislop, Temitope E Adewuyi, Luke D Vale, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 12, 2019
Validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Summary Score in Patients With Hematologic MalignanciesFabio Efficace, Francesco Cottone, Kathrin Sommer, et al.
Health Technology Assessment (Winchester, England)|May 9, 2014
Assessing methods to specify the target difference for a randomised controlled trial: DELTA (Difference ELicitation in TriAls) reviewJonathan A Cook, Jennifer Hislop, Temitope E Adewuyi, et al.
Journal of Pain and Symptom Management|November 5, 2016
Development of the EORTC QLQ-CAX24, A Questionnaire for Cancer Patients With CachexiaSally J Wheelwright, Jane B Hopkinson, Anne-Sophie Darlington, et al.
The Lancet. Oncology|September 25, 2010
Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trialPeter Gimsing, Kristina Carlson, Ingemar Turesson, et al.
Targeted Oncology|November 9, 2020
Developing Symptom Lists for People with Cancer Treated with Targeted TherapiesSamantha C Sodergren, Sally J Wheelwright, Deborah Fitzsimmons, et al.
Pageof 9